Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • India pharma exports...

    India pharma exports may see near double-digit growth in FY17: Official

    Written by supriya kashyap kashyap Published On 2017-02-11T09:58:58+05:30  |  Updated On 11 Feb 2017 9:58 AM IST
    India pharma exports may see near double-digit growth in FY17: Official

    Hyderabad : Indian pharma exports in the current financial year may see a near double-digit growth and might end up on the lines with that of last year, a senior Ministry of Commerce and Industry official said here.


    "Pharma exports have done better than many sectorial exports and we are in near double digit growth. Last month, growth has also been good it is about 8 per cent. So I see that despite overall contraction and slowdown, pharma exports doing relatively better. I don t think that it (double digit growth) would be possible," Sudhanshu Pandey, Joint Secretary, Commerce Ministry told reporters on the sidelines of BioAsia- 2017, when asked if the exports would see double digit growth this year.


    "We should be some way between 8 to 10 per cent. That is what is the anticipation, he


    Indian Pharma exports stood at USD 16.9 billion in the last financial year, growing at 9.44 per cent with USD 5.7 billion to USA and USD 3.3 billion to Africa, as per the statistics supplied by Pharmexcil. The exports stood at USD 15.4 billion in 2014-15.


    Pandey said there may not be much impact of Brexit on pharma exports in either Britain or Europe as the situation has stabilised with regard to exports to those geographies.


    "You have already seen impact on the exports but now exports have in fact stabilised and there is growth in the last month. So I think the trend would be in that direction," he said.


    Replying to query, he said Indian Institutes of Chemical Technology (IICT) will offer space to industry either for setting up a startup incubator or for research purpose.


    According to Pandey, NITI Aayog is working on model wherein the government will be able to invest in some of the risk oriented research programmes.

    double-digit growthIICTIndian Institutes of Chemical Technologyindian pharmaNiti AayogPharmexcilSudhanshu Pandey
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok